Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS-Reference-Cited by-同舟云学术

Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS

Published:1995-11-17 Issue:5239 Volume:270 Page:1194-1197
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Rice William G.¹,Supko Jeffrey G.²,Malspeis Louis²,Buckheit Robert W.³,Clanton David⁴,Bu Ming¹,Graham Lisa¹,Schaeffer Catherine A.¹,Turpin Jim A.¹,Domagala John⁵,Gogliotti Rocco⁵,Bader John P.⁶,Halliday Susan M.³,Coren Lori⁷,Sowder Raymond C.⁷,Arthur Larry O.⁷,Henderson Louis E.⁷

Affiliation:

1. W. G. Rice, M. Bu, L. Graham, C. A. Schaeffer, J. A. Turpin, Laboratory of Antiviral Drug Mechanisms, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.

2. J. G. Supko and L. Malspeis, Laboratory of Pharmaceutical Chemistry, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Frederick, MD 21701-8527, USA.

3. R. W. Buckheit Jr. and S. M. Halliday, Virology Research Group, Southern Research Institute-Frederick Research Center, Frederick, MD 21701, USA.

4. D. Clanton, Anti-AIDS Virus Drug Screening Laboratory, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.

5. J. Domagala and R. Gogliotti, Chemistry Department, Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.

6. J. P. Bader, Antiviral Evaluations Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892, USA.

7. L. Coren, R. C. Sowder II, L. O. Arthur, L. E. Henderson, AIDS Vaccine Program, PRI/DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference30 articles.

1. MUTATIONS OF RNA AND PROTEIN SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING RESULT IN PRODUCTION OF NONINFECTIOUS VIRUS;ALDOVINI A;JOURNAL OF VIROLOGY,1990

2. POTENTIAL METAL-BINDING DOMAINS IN NUCLEIC-ACID BINDING-PROTEINS;BERG J.M.;SCIENCE,1986

3. TIGHTLY BOUND ZINC IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I, AND OTHER RETROVIRUSES;BESS J.W.;JOURNAL OF VIROLOGY,1992

4. THIAZOLOBENZIMIDAZOLE - BIOLOGICAL AND BIOCHEMICAL ANTIRETROVIRAL ACTIVITY OF A NEW NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR;BUCKHEIT R.W.;ANTIVIRAL RESEARCH,1993

5. BIOLOGICAL AND BIOCHEMICAL ANTI-HIV ACTIVITY OF THE BENZOTHIADIAZINE CLASS OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS;BUCKHEIT R.W.;ANTIVIRAL RESEARCH,1994

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prodrug Strategy Extends the Use of Anti-HIV Sulfanylbenzamides for Application In Vivo;ACS Pharmacology & Translational Science;2023-12-14

2. Long way up: rethink diseases in light of phase separation and phase transition;Protein & Cell;2023-12-09

3. Droplets of life: role of phase separation in virus replication and compartmentalization;Droplets of Life;2023

4. Mercapto-Benzamide Inhibitors effects on HIV NCp7 Protein: a parameter-free DFT based structural study;IOP Conference Series: Materials Science and Engineering;2022-11-01

5. Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection;Bioorganic & Medicinal Chemistry;2022-08